Accelerate Diagnostics Annual Income Statement (NASDAQ:AXDX)

Add to My Stocks
$23.1 $0.45 (1.91%) AXDX stock closing price Mar 29, 2017 (Closing)

Financial analysis of Accelerate Diagnostics involves more than just checking the Accelerate Diagnostics stock price, by looking at the financial statements of the company in detail. The income statement is a summary of the revenue, expenses and profitability (shown as Net Income) or lack of it. Like any other income statement, the AXDX income statement also itemizes revenue, operating expenses, and profits for a quarter or year and reflects a YoY revenue growth of $0.02M when compared to the same period in the past. The operating expenses (also check: Accelerate Diagnostics assets and Accelerate Diagnostics free cash flow) as shown in the Accelerate Diagnostics profit and loss statement 2015 total to $45.69M. This line item has increased from $31.63M compared with last year. Accelerate Diagnostics revenue for 2015 is $0.14M. View revenue and profit details for latest and last 10 financial years.

show more
Annual
Quarterly
View Previous Years
View Next Years
Fiscal year is Jan - Dec. 2015 2014 2013 2012 2011 2010 2009 2008 2007
Accelerate Diagnostics Net Sales or Revenues
0.14M0.12M0.04M-1.12M2.24M1.26M0.47M0.18M
Cost Of Goods Sold (COGS)-------0.01M0.05M
Accelerate Diagnostics Gross Profit
0.14M0.12M0.04M-1.12M2.24M1.26M0.46M0.12M
Research & Development Expense26.02M20.05M10.67M-0.45M0.5M0.74M0.88M0.99M
Selling General & Admin Expense17.88M10.69M4.31M-0.81M0.87M0.93M1.01M0.93M
Income Before Depreciation Depletion Amortization-43.75M-30.62M-14.93M--0.15M0.87M-0.4M-1.43M-1.8M
Depreciation Depletion Amortization1.79M0.89M0.37M-0.25M0.26M0.27M0.29M0.31M
Non Operating Income0.07M0.06M0.02M-0.03M0.02M-0.03M0.04M0.19M
Interest Expense0.02M0.01M-------
Accelerate Diagnostics Pretax Income
-45.49M-31.46M-15.28M--0.37M0.64M-0.71M-1.68M-1.92M
Provision for Income Taxes--0.52M-------
Minority Interest---------
Investment Gains Losses---------
Other Income---------
Income Before Extraordinaries & Disc Operations-45.49M-30.93M-15.28M--0.37M0.64M-0.71M-1.68M-1.92M
Extraordinary Items & Discontinued Operations---------
Accelerate Diagnostics Net Income (Profit/Loss)
-45.49M-30.93M-15.28M--0.37M0.64M-0.71M-1.68M-1.92M
Average Shares used to compute Diluted EPS45M43.63M37.5M12.43M10.79M10.41M10.23M10.06M10.11M
Average Shares used to compute Basic EPS45M43.63M37.5M12.43M10.79M10.41M10.23M10.06M10.11M
Income Before Nonrecurring Items-45.5M-30.93M-15.28M-5.31M-0.38M0.64M-0.71M-1.68M-1.92M
Income from Nonrecurring Items---------
Accelerate Diagnostics Earnings Per Share Basic Net
-1.01-0.71-0.41-0.43-0.040.06-0.07-0.17-0.19
Accelerate Diagnostics Earnings Per Share Diluted Net
-1.01-0.71-0.41-0.43-0.040.06-0.07-0.17-0.19
EPS Diluted Before Nonrecurring Items-1.01-0.71-0.41-0.43-0.040.06-0.07-0.17-0.19
Preferred Dividends Acc Pd---------
Dividends Common---------
Dividend Per Share Common---------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years
Get Income statement for another ticker

1:25
AXDX
Accelerate Diagnostics stock analysis involves checking at least a few of the important things like:
  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that AXDX stock has a topline or revenue of $0.14M for 2015 as per this Accelerate Diagnostics revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $-45.49M for Accelerate Diagnostics for 2015. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.
The income statement is also called the profit and loss statement. Apart from the income statement, one can check the Accelerate Diagnostics historical stock prices to check how the price has moved with time. .

Accelerate Diagnostics Income Statement - Key Financial Ratios

PS ratio (
price sales ratio
)
5009.8125
Operating margin
-40075
Net profit margin
-40350
Dividend yield
0%